GE HealthCare has announced the release of MyBreastAI Suite, a new AI-powered platform for mammography, designed to aid clinicians in detecting breast cancer. This platform integrates AI applications from iCAD, focusing on breast density assessment and enhancing the efficiency of mammography workflows.

Addressing the challenges posed by the global rise in breast cancer cases, MyBreastAI Suite aims to streamline breast cancer detection. The platform includes three key AI applications from iCAD’s ProFound Breast Health Suite:

  1. ProFound AI for DBT: Provides lesion Certainty of Finding and Case Scores, aiding radiologists in decision-making and potentially reducing reading time by up to 52%.
  2. SecondLook for 2D Mammography: Aids in identifying regions of interest on mammograms to assist radiologists in their assessments.
  3. PowerLook Density Assessment: Standardizes breast density assessment, reducing variability and providing accurate, AI-based analysis.

“As part of GE HealthCare’s ongoing commitment to transform healthcare and improve patient outcomes, we continue to explore how we can leverage the power of AI in mammography to support the early detection of breast cancer,” says Pooja Pathak – Vice President and General Manager of Mammography. “As screening guidelines continue to evolve and more attention is given to personal risk factors such as breast density, these kinds of tools are an important and exciting addition to our comprehensive portfolio of breast imaging technologies.”

“Through this new all-in-one AI platform designed to offer radiologists enhanced clinical decision support and streamlined workflows, clinicians will be able to deliver more timely, accurate and personalized breast care in their practices today. We know that early detection is key and AI solutions show great promise in advancing breast cancer screening and transforming workflow for radiologists,” says Mario Lois – General Manager of AI for Women’s Health.

MyBreastAI Suite will be initially available in the United States as part of GE HealthCare’s Senographe Pristina mammography portfolio.

Show CommentsClose Comments

Leave a comment